Lymphoma is a cancer that starts in the infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. There are many types of lymphoma, and the risk factors vary.
If you have coronary artery disease, congestive heart failure, atrial fibrillation or any other heart condition, what does this mean for you if you have cancer? It means you should seek a consultation with a cardio-oncologist.
You may not realize it, but your body is home to a lot of microbes — way more than you might think. In healthy humans, “microbial cells outnumber human cells by about ten to one,” according to the Human Microbiome Project of the National Institutes of Health. Most of them, called gut flora, live in your digestive system, especially in the colon. Others live in distinct communities in and on your body, in different types of environments — hot or cold, moist or dry.
The U.S. Food and Drug Administration approved a new indication for the oral drug lenalidomide (brand name Revlimid) as a maintenance therapy for multiple myeloma patients following autologous hematopoietic stem cell transplant (ASCT), also known as autologous blood and marrow transplant (BMT).
Thyroid nodules are common and found in 10 percent of the adult population. Luckily, 95 percent of them are benign. When a thyroid nodule is suspicious - meaning that it has characteristics that suggest thyroid cancer - the next step is usually a fine needle aspiration biopsy (FNAB).
If your treatment plan includes surgery, the recovery process may seem overwhelming. You may be on a restricted diet or experience limited movement and pain after a major operation. Enhanced Recovery After Surgery (ERAS) is a program that allows for a smoother, faster recovery by changing the way you prepare for surgery and your post-op care.
The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.
In January 2017, the agency, a member institution of the National Institutes of Health, launched the NCI Formulary to expand access to both approved drugs and investigational agents — that is, drugs still in development — that have shown promise as possible cancer therapies.
During my post-doctoral fellowship at Roswell Park, I found my true calling – to help students discover their passion for science.